BMT
Beamtree Holdings Limited
🇦🇺 ASX
📈 HIGH PRICE GROWTH
🩺 HEALTH CARE
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
+ 10.91%
Annual Growth
5 years average annual growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
5
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Beamtree Holdings Ltd. is an Australian healthcare technology company, which engages in the proprietary subscription based CDS called RippleDown that automates the human decision-making process within healthcare organizations based on rules set within the organization by domain experts. The company is headquartered in Sydney, New South Wales and currently employs 95 full-time employees. The company went IPO on 2019-06-06. The firm provides automation technology and data analytics that support health care providers. The firm's segments include diagnostic technology, clinical decision support, coding assistance and data quality, analytics and knowledge networks. The diagnostic technology segment includes its RippleDown products, which automate decision making in clinical and administrative processes in pathology. Its automation of clinical record coding and data integrity products include its RippleDown and Performance Indicators for Coding Quality coding technologies (PICQ). Its clinical decision support segment includes Ainsoff Deterioration Index, which is a machine learning-based tool that predicts the risk of patient deterioration and alerts clinicians in real time. Its products also include advisory and auditing, Q coding platform, and Relative Indicators for Safety and Quality.
📈 Performance
Price History
+27.50%
1M
1Y
All Time
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.26
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in BMT
5
📊 Total Capital Earnings
$2K
🔃 Average investment frequency
17 weeks
💵 Average investment amount
$542
⏰ Last time a customer invested in BMT
171 days
BMT investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
44%
50k - 100k
33%
Less than 50k
11%
👶 Age of investors
18 - 25
26 - 34
20%
35 - 90
80%
🙋 Legal gender of investors
Female
60%
Male
40%
Pearlers who invest in BMT also invest in...
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
3.85%
📊 Share price
$100.90 AUD
⛳️ DIVERSIFIED
🇦🇺 AUSTRALIA
🧱 MATERIALS
💸 FINANCIALS
IVV.AX was created on 2007-10-10 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.
🙌 Performance (5Yr p.a)
18.86%
📊 Share price
$57.74 AUD
📈 HIGH PRICE GROWTH
🇺🇸 UNITED STATES
Imugene Ltd. is a biopharmaceutical company, which engages in the research, development, and commercialisation of health technologies against cancer. The company is headquartered in Sydney, New South Wales. The company is engaged in developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumors. Its platform technology seeks to harness and promote the body’s immune system against cancerous tumors. Its product pipeline includes an off-the-shelf (allogeneic) cell therapy CAR T drug Azer-Cel (azercabtagene zapreleucel) which targets CD19 to attack blood cancer. Its pipeline includes an Oncolytic Virus and B-Cell Immunotherapies aimed at treating a variety of cancers in combination with standard of care drugs and immunotherapies. Its lead candidate is a chimeric vaccinia (pox) virus known as CF33, which is a combination of genomic sequences from multiple vaccinia virus strains to generate a new, safer and more potent virus. Its Chimeric antigen receptor (CAR)-engineered T cells (CAR T) are T cells redirected against tumors through engineered expression of CARs.
🙌 Performance (5Yr p.a)
20.87%
📊 Share price
$0.05 AUD
🧬 BIOTECHNOLOGY
📈 HIGH PRICE GROWTH
BigTinCan Holdings Ltd. is a global software company, which engages in providing AI-powered sales enablement automation platform. The company is headquartered in Sydney, New South Wales. The company went IPO on 2017-03-24. The firm provides an artificial intelligence (AI)-powered sales enablement automation platform. The Company’s principal activity is the provision of an integrated, online platform, Bigtincan Hub, a collaborative and secure solution that automatically delivers the relevant content to the right users directly, across any device and any network. The company provides software as a service (SaaS) application platform, creating a comprehensive solution that offers customers tools for sales content management (Bigtincan Content Hub), sales readiness (Learning Hub) and sales engagement (Engagement Hub), which is engaged in working together to create its Intelligent Enablement Platform (IEP). The firm operates globally with users in over 50 countries and with a solution localized into approximately 40 languages. Its products are used by various companies across the world, with over 2000 deployments and more than one million users.
🙌 Performance (5Yr p.a)
-14.80%
📊 Share price
$0.17 AUD
🤖 TECHNOLOGY
VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
12.86%
📊 Share price
$129.54 AUD
🌏 GLOBAL
⛳️ DIVERSIFIED
🤖 TECHNOLOGY
📈 HIGH PRICE GROWTH
Want more shares? Try these...
BNDS.AX was created on 2018-11-07 by BetaShares. The fund's investment portfolio concentrates primarily on broad credit fixed income. The Fund aims to earn an after fee return in excess of the Bloomberg AusBond Composite 0+yr Index over rolling three year periods.
🙌 Performance (5Yr p.a)
-2.75%
📊 Share price
$23.25 AUD
BNKS.AX was created on 2016-07-28 by BetaShares. The fund's investment portfolio concentrates primarily on financials equity. BNKS.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global banks (ex-Australia), hedged into Australian dollars.
🙌 Performance (5Yr p.a)
4.03%
📊 Share price
$8.11 AUD
🇦🇺 EX AUSTRALIA
Ballymore Resources Ltd. engages in the identification, development, and exploration of mineral resources. The company is headquartered in Brisbane, Queensland. The company went IPO on 2021-09-03. The firm holds a portfolio of exploration and development projects in the Queensland mineral belts that are prospective for gold and base metals. These consist of about two granted Mining Leases (MLs), 14 Exploration Permits over four project areas at Dittmer, Ruddygore, Ravenswood, and Mount Molloy. The Dittmer Project covers an area of approximately 488 square kilometers and is located about 20-50 kilometers (km) west and southwest of the regional center of Proserpine in central Queensland. The Ruddygore Project is located adjacent to the regional center of Chillagoe in north Queensland and consists of four granted EPMs with an area of about 558 square kilometers. The Ravenswood Project covers an area of about 309 square kilometers and is located to the south and east of Charters Towers. The Mount Molloy Project is located south of the town of Mount Molloy and approximately 50 km northwest of Cairns.
📊 Share price
$0.14 AUD
⛏️ MINING